Difficulty: Medium
Average Score: 67%
Practice
A 25-year-old man with multiple sexual partners begins to have flulike symptoms. He visits his doctor who recommends an HIV screening test based on his history. He is found to have an HIV infection and begins a drug regimen. Which of the following works by inhibiting fusion of the virion with T cells?
Correct answer
D
Rationale
The correct answer is D) Maraviroc. Maraviroc is a CCR5 antagonist that works by inhibiting the fusion of the HIV virion with the CD4 T cell. This prevents the virus from entering the cell and replicating.
Option A) Darunavir is a protease inhibitor that works by blocking the protease enzyme, necessary for viral replication. Option B) Delavirdine is a non-nucleoside reverse transcriptase inhibitor that blocks the reverse transcriptase enzyme. Option C) Efavirenz is another non-nucleoside reverse transcriptase inhibitor that works similarly to Delavirdine.
In an educational context, understanding the mechanisms of action of different classes of antiretroviral drugs is crucial for healthcare professionals managing patients with HIV. By knowing how each drug works, healthcare providers can make informed decisions when selecting the most appropriate regimen for individual patients based on factors like drug resistance and potential side effects. Understanding the specific action of Maraviroc in inhibiting fusion can help in designing effective treatment plans for patients with HIV.
Option A) Darunavir is a protease inhibitor that works by blocking the protease enzyme, necessary for viral replication. Option B) Delavirdine is a non-nucleoside reverse transcriptase inhibitor that blocks the reverse transcriptase enzyme. Option C) Efavirenz is another non-nucleoside reverse transcriptase inhibitor that works similarly to Delavirdine.
In an educational context, understanding the mechanisms of action of different classes of antiretroviral drugs is crucial for healthcare professionals managing patients with HIV. By knowing how each drug works, healthcare providers can make informed decisions when selecting the most appropriate regimen for individual patients based on factors like drug resistance and potential side effects. Understanding the specific action of Maraviroc in inhibiting fusion can help in designing effective treatment plans for patients with HIV.